Table 2.

Parameter Estimates of Longitudinal Modeling of Outcome Variables

Parameter	Estimate	S.E.*	p-value
Model-I: CD4 T-Cell Counts
Time	-0.003	0.003	0.195
Gender	-0.088	0.101	0.383
Race	-0.238	0.101	0.018
Treatment
Mono Therapy	0.279	0.055	<0.001
Dual Therapy	0.105	0.029	<0.001
HAART	0.246	0.026	<0.001
Triple Nucleoside	0.137	0.031	<0.001
Other Infections	-0.253	0.099	0.011
Mode of Transmission	-0.165	0.146	0.257
Model-II: CD4-Percent
Time	-0.019	0.049	0.698
Gender	-2.513	2.402	0.296
Race	-5.560	2.399	0.021
Treatment
Mono Therapy	5.871	1.282	<0.001
Dual Therapy	2.889	0.677	<0.001
HAART	5.174	0.609	<0.001
Triple Nucleoside	3.142	0.728	<0.001
Other Infections	-6.975	2.365	0.003
Mode of Transmission	-3.358	3.471	0.333
Model-III: Viral Load
Time	-0.539	0.349	0.129
Gender	-8.874	18.052	0.623
Race	4.825	18.013	0.789
Treatment
Mono Therapy	-16.692	21.599	0.439
Dual Therapy	-57.206	11.192	<0.001
HAART	-86.023	10.150	<0.001
Triple Nucleoside	-22.382	12.172	0.066
Other Infections	52.850	17.878	0.003
Mode of Transmission	18.669	26.681	0.484

^*Standard error